TickerFacts.

Veradermics, Inc (MANE): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$121.01M
As of 2025-12-31
$813.61M
As of 2026-06-30
2024-12-31: -$48.48M2025-12-31: -$121.01M-$121.01M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$121.01Mn/m2026-03-30, Balance as of period end
2024-12-31-$48.48Mn/a2026-03-30, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Veradermics, Inc (MANE)2025-12-31-$121.01Mn/m
CytomX Therapeutics, Inc. (CTMX)2025-12-31$99.01Mn/m
Ovid Therapeutics Inc. (OVID)2025-12-31$130.66M+91.5%
Whitehawk Therapeutics, Inc. (WHWK)2025-12-31$136.31M+159.7%
Xilio Therapeutics, Inc. (XLO)2025-12-31$35.27M+100.4%
XBiotech Inc. (XBIT)2025-12-31$140.35M-23.0%
Precigen, Inc. (PGEN)2025-12-31$20.91M-45.7%
Boundless Bio, Inc. (BOLD)2025-12-31$98.65M-34.5%
Larimar Therapeutics, Inc. (LRMR)2025-12-31$78.08M-54.6%

Compare MANE, CTMX, OVID, WHWK side by side · Screen every company in Pharmaceutical Preparations ↗